Mcguirewoods Alyssa Campbell And Kayla Mccann Marty public
[search 0]
More
Download the App!
show episodes
 
Artwork

1
Across the Table

McGuireWoods - Alyssa Campbell and Kayla McCann Marty

Unsubscribe
Unsubscribe
Monthly
 
Welcome to Across the Table, a healthcare private equity podcast brought to you by McGuireWoods. Across the Table brings you timely and relevant discussions with the specialists and professionals of the healthcare private equity and finance industry on such topics as distressed assets, add-ons, and mergers and acquisitions (M&A) and more. We’ll share the latest developments, provide insight, identify issues and talk takeaways. McGuireWoods is a full-service firm providing legal and public af ...
  continue reading
 
Loading …
show series
 
In this special crossover edition of Across the Table, we're excited to republish an insightful episode from our sister podcast, Deal-by-Deal. Host Greg Hawver talks to fellow McGuireWoods partner Holden Brooks about antitrust considerations for private equity investors in the middle market (and, interestingly, the lower middle market). They begin …
  continue reading
 
On this episode of Across the Table, host Kayla McCann Marty is joined by Alexis Rathborne, Managing Director of Investments at Trident for a discussion on the healthcare market and the investment thesis driving Trident’s team. Alexis explains how she applies Trident’s investment thesis – that identifying the right investment and operating partners…
  continue reading
 
When leading a company, few things are as important as building a strong team and empowering those team members, according to Matthew Pettit, founding partner of Seven Hills Capital. Before Matt formed Seven Hills Capital, he founded and worked as CEO of another successful business, Ascend Dermatology. His goal was to create an organization that pr…
  continue reading
 
On this episode of Across The Table, McGuireWoods partner Alyssa Campbell is joined by Colin McDermott and Savanna Ganyard of VMG health for a discussion of the publicly traded healthcare operator’s Q1 earnings reports, along with expectations for the rest of 2023. They also touch on whether today’s investment climate reflects a return to typical h…
  continue reading
 
Honesty and trust are two of the most important elements of any strong relationship. The same is true for the business relationship between private practice physicians and investors, according to Andrea Balogh who joins host Kayla McCann Marty for this episode of Across The Table. Andrea is the Chief Growth Officer and Chief Legal Officer at Integr…
  continue reading
 
In a “post-COVID” world, specialty care centers are trying to keep up with the ever-changing landscape of the healthcare market. On this episode of Across the Table, host Kayla McCann Marty talks with Kyle Lynch, a Group Vice President of Development at SCA Health, which is part of OptumCare and is a leader in specialty care, practice management so…
  continue reading
 
Paul Barrett isn’t afraid to get in the weeds to help an entrepreneur in the healthcare industry fulfill their vision. He and his team at Argosy Healthcare Partners pride themselves on seeking out organizations with smaller EBITDAs. The way Paul sees it, both sides win with this approach. Argosy avoids the stiff competition that comes with high-wor…
  continue reading
 
As a private equity borrower in the ever-changing healthcare field, you have leverage in your deals with lenders. Penny Zacharias, Clayton Stallbaumer, and Ying Hsu are all partners in McGuireWoods’ debt finance group. They regularly work on sponsor-backed lending transactions in the healthcare space, and are particularly familiar with the borrower…
  continue reading
 
Investment in the healthcare sector is as strong as ever, but balancing risk and profit can be tricky when it comes to consolidation. Doctors want reassurance and investors want lucrative deals. How do you find the balance? Rajesh Kothari, Founder and Managing Director of Cascade Partners, offers his insight and experience on the outlook of investi…
  continue reading
 
Healthcare investing is experiencing a gold rush — thanks to the explosion of investments in healthcare technology since the onset of the COVID-19 pandemic. Scott Becker, Partner at McGuireWoods and the Founder and Publisher of Becker’s Healthcare, joins the podcast to share insights on healthcare technology investments. Investments in healthcare t…
  continue reading
 
Paper is so yesterday — and the team at healthcare and financial technology growth company Zelis knows this firsthand. Eric Schaefer and Yusuf Qasim, Zelis’ Executive Advisor and President of Payments, respectively, focus on strategy and market direction to adapt in an ever-changing healthcare landscape. The industry’s increasing dependence on tech…
  continue reading
 
The COVID-19 pandemic fast-tracked an already expanding telehealth industry, and while there is no doubt about the convenience this will create for health consumers, the complexities of implementing these practices go far beyond the creation of apps for patients to communicate and share data with their doctors. Janice M. Suchyta and Andrea Linna, P…
  continue reading
 
Undeniably, the COVID-19 pandemic has changed the lives of billions across the world. It's caused great suffering, altered the way we go about our daily lives, and transformed the healthcare industry too. One major consequence of the pandemic: the shift toward home health. "Families recognize the imperative of trying to keep their loved ones comfor…
  continue reading
 
Pharmacy benefit managers are the middleman in the drug supply chain, but over the past few years, there's been a great deal of controversy with respect to their role. Kate Hardey, a partner at McGuireWoods, wants you to better understand the role of PBMs. “When you think of a pharmacy, your insurance normally pays for your prescription,” she says …
  continue reading
 
When considering a private equity partner for your physician practice group, there are several factors to consider that are just as important as the economics of the deal. To ensure a successful working relationship after the deal is done, it’s imperative to identify not only the right cultural fit for your practice but to ensure the partner posses…
  continue reading
 
In light of the continuous technological advances in the healthcare field, the question arises, how do we keep people healthy while keeping them out of the hospital? With increasing medical costs and potential exposure to disease, what can the US Healthcare system do to ensure high-quality care while easing the burdens on the healthcare system and …
  continue reading
 
The modern world has seen the healthcare system evolve and join forces with complementary disciplines in an effort to provide superior solutions and services. A prime example is the relationship between private equity and healthcare, with companies in these sectors identifying significant growth in provider-driven joint ventures. Tackling the evolu…
  continue reading
 
As the world works to recover from the COVID-19 pandemic, businesses are starting to open up shop and resume operations. While certain sectors of the healthcare industry have been largely unaffected by the crisis, others have suffered severe losses. This volatility has contributed to a growing interest in mergers and acquisitions, both on the buyer…
  continue reading
 
Across a multitude of industries, businesses are still reeling from the impacts of the COVID-19 pandemic. Companies in some sectors are uncertain if recovery is even on the horizon for them or just how long it’s going to take if their markets do recover. Conversely, some providers are keen to expand and diversify their platform, even considering en…
  continue reading
 
As states are relaxing stay-at-home protocols and other Coronavirus-related policies, many businesses are resuming operations. Healthcare providers that shuttered their practices during the pandemic are beginning to receive patients again. And, while the threat of the virus remains, clinics and institutions will need to eventually open not only to …
  continue reading
 
It’s too early to speculate how companies in the healthcare industry will weather the current crisis as the world is still in the trenches of the pandemic. While companies are going to rebound and bounce back more robust than ever, some may not be as successful. And, with M&A transactions still on the horizon, investors remain vigilant for valuable…
  continue reading
 
As the bulk of the healthcare industry is focused on responding to the Coronavirus and COVID-19 pandemic, it’s inevitable that many medical practices will face economic loss and financial duress. It’s expected that distressed transactions and investing will continue even months after the crisis slows down. In this episode of Across the Table, hosts…
  continue reading
 
It’s an unfortunate reality, but a number of companies are failing to adequately navigate today’s rapidly evolving climate. However, there is still hope for these distressed businesses as there will always be those on the look out to acquire or purchase them. In this inaugural episode of Across the Table, hosts Holly Buckley and Geoff Cockrell spea…
  continue reading
 
Welcome to Across the Table, a healthcare private equity podcast brought to you by McGuireWoods. Across the Table brings you inside the conversation with the specialists and professionals of the healthcare private equity industry. To learn more about McGuireWoods or to contact us, please visit our website at mcguirewoods.com. This podcast was recor…
  continue reading
 
Loading …

Quick Reference Guide